Brian L VanderBeek MD MPH MSCE
Retinal Disease
Assistant Professor, Ophthalmology, Perelman School of Medicine
Join to View Full Profile
51 N. 39th StreetPhiladelphia, PA 19104
Phone+1 215-662-8676
Dr. VanderBeek is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Michigan Health SystemFellowship, Surgical Retina and Vitreous, 2009 - 2011
New York Presbyterian Hospital (Cornell Campus)Residency, Ophthalmology, 2006 - 2009
Christ HospitalInternship, Internal Medicine, 2005 - 2006
University of Cincinnati College of MedicineClass of 2005
Certifications & Licensure
PA State Medical License 2011 - 2026
MI State Medical License 2009 - 2013
NY State Medical License 2007 - 2010
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- Racial and Ethnic Disparities at Enrollment in DRCRnet Clinical Trials for Diabetic Macular Edema.Melissa Li, Jocelyn He, Brian L Vanderbeek, Gui-Shuang Ying
American Journal of Ophthalmology. 2025-05-01 - National opioid prescription decline across outpatient specialty surgeries: a claims database study.Surya A Veerabagu, Shannon T Nugent, Zhi Geng, Arianna F Yanes, John P Fischer
Journal of the American Academy of Dermatology. 2025-04-14 - Providing for Proliferative Diabetic Retinopathy in Our Neighborhoods.Jonathan C Tsui, Brian L VanderBeek
Ophthalmology. Retina. 2025-02-01
Journal Articles
- Curtailing Opioid Overprescribing in OphthalmologyAnton M Kolomeyer, Brian L Vanderbeek, JAMA Ophthalmology
Press Mentions
Sexual-Enhancement Drugs Raise Risk of Vision ImpairmentApril 18th, 2022- Erectile Dysfunction Drugs Linked to Vision LossApril 11th, 2022
- ED Meds Linked to Higher Risk of Ocular Adverse EventsApril 7th, 2022
- Join now to see all
Grant Support
- Trends in US Rates of Diabetic Retinal DiseaseUNIVERSITY OF PENNSYLVANIA2024–2025
- Trends in US Rates of Diabetic Retinal DiseaseUNIVERSITY OF PENNSYLVANIA2024–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
